1
Understanding Human ES Cells vs. iPS Cells and Analyzing RT-PCR Data
Student’s
Institution
Course
Instructor
Date
2
Introduction
The assignment requires a critical analysis of human embryonic stem (ES) cells and
induced pluripotent stem (iPS) cells with respect of their similarity and differences, together with
the associated ethical issues. Second, it needs a detailed examination of an RT-PCR experiment
described in Figure 3 in Unit 1 Paper 4 for the rationale of this experiment, its methodology, and
conclusions derived from data sequences (Zheng, et al. 2019). This step is taken to bring together
knowledge one has gained from stem cell biology and techniques in experiments to reap an
assessment of the potential of both kinds of cells and their implications.
Comparison of Human ES and iPS Cells
A. Similarities and Differences
Human ES Cells:
Human embryonic stem cells are obtained from the inner cell mass of a blastocyst, which
is an embryo at an early stage of development (Reubinoff et al., 2020). They are pluripotent cells
with the capability to differentiate into almost every cell type in the body and are, therefore, of
great importance for research and probably therapies.
Pluripotency means that ES and iPS cells are pluripotent; in other words, they can give
rise to cells of multiple lineages (Takahashi et al., 2007). This feature plays a vital role in
regenerative medicine and the modelling of diseases. Hence, such cells can become any type
required in therapy or research, thus serving as powerful tools for regenerative medicine and
tissue engineering.
3
Self-Renewal: Under such conditions, both cell types can self—renew, an essential
property for the in vitro expansion of stem cell populations (Takahashi et al., 2007). The
requirement of self-renewal is always that the cells can proliferate indefinitely while remaining
undifferentiated; thus, large numbers of cells can be generated for experimental or therapeutic
use.
Derivation: The ES cells are derived from embryos; therefore, specific ethical concerns
are raised concerning the embryo's destruction. Any work on an embryo is associated with
several critical ethical debates concerned with this point of view about the moral status of an
embryo and its implications regarding its destruction (Thomson et al., 1998). on the other hand,
iPS cells are produced by reprogramming adult somatic cells into embryonic-like states, usually
fibroblasts. This procedure bypasses the ethical concerns of using embryos and offers a much
more ethically palatable method for creating pluripotent cells.
Human iPS Cells:
Induced Pluripotent Stem (iPS) cells are obtained by introducing definite transcription
factors—like Oct4, Sox2, Klf4, and c-Myc—into adult somatic cells. Such introduction leads to
reprogramming these cells into a state that is pluripotent and similar to that of ES cells.
Gene Editing Method: iPS cells are generated by reverting adult cells into a cell state
that is very similar to the ones of ES cells. Generation of such cells does not require embryos;
therefore, many ethical problems arising from the application of ES cells simply disappear.
Genetic Stability: While iPS cells are equivalent to ES cells in terms of pluripotency,
they might have a heterogeneity of genomic and epigenomic nature due to the process of
4
reprogramming (Thomson et al. 1998). That may influence their behavior and differentiation
potential.
Tumorigenicity: Both ES and iPS cells can form tumors, termed teratomas, when
transplanted. There is a greater chance of these happening through iPS cells due to residual
reprogramming factors.
Advantages and Disadvantages:
ES Cells:
Advantages: High degree of pluripotency and the ability to differentiate
into any cell type; extensive research background.
Disadvantages: The use of embryos is ethically controversial. In the case
of therapy, it has the disadvantage of immune rejection.
iPS Cells:
Advantage: One advantage is that many of the ethical issues related to the
use of embryos can be avoided. If it is derived from the patient itself, then immune
rejection can be reduced.
Observable Disadvantages: Genetic abnormalities due to reprogramming,
incomplete reprogramming can show an effect on two major issues of differentiation and
safety.
B. Ethical Considerations
Human ES Cells:
5
Ethical advantages: Using ES cells will advance scientific knowledge and potential
therapies greatly by showing how very early stages of development and mechanisms for diseases
take place. As they may transform into every cell type, they represent a basic tool for
understanding complicated biological processes and developing new treatments for several
diseases (Reubinoff et al. 2020). In addition to that, ES cells provide a unique way of studying
human biology at the cellular level, making it possible to make progress in regard to regenerative
medicine and health care on a personalized basis.
Ethical Disadvantages: ES cells are extracted through the destruction of human embryos,
which gives rise to significant moral concerns regarding when life truly begins and what rights
an embryo has (Thomson et al. 1998). Critics have argued that this is akin to treading underfoot
real potential human lives and, as such, opposes the ethical considerations regarding the value
and sacredness of the embryo. Moreover, one of the most difficult issues in the ethical debate on
stem cell research has been the debate over whether the potential benefits outweigh the moral
costs.
Human iPS Cells:
Ethical Advantages: iPS cells overcome the bulk of ethical concerns associated with ES
cells, simply as they don't require embryos sequences (Zheng, et al. 2019). They, therefore, offer
a route to personalized medicine through the creation of patient-specific cell lines
Ethical Disadvantages: Though most of the ethical issues are absent, reprogramming
can still be plagued by some of the problems associated with the techniques mentioned above,
like possible genetic mutations and long-term effects that must be scrupulously monitored.
6
C. Reasons for Generating iPS Cells
Ethical Issues: The development of iPS cells was done to avoid all the ethical problems
linked with the use of human embryos in research studies (Takahashi, et al. 2007). This way, by
reprogramming adult cells, one will have pluripotent cells not accompanied by the moral
dilemmas of embryo destruction.
Personalized Medicine: It allows for personalized medicine, in which generation of iPS
cells from a patient will help create relevant cell lines to model the disease and test drugs
sequences (Zheng, et al. 2019). Thus, it may lead to far more powerful and customized
treatments apart from offering insight into individual patient responses.
Analyzing Figure 3: RT-PCR Analysis
A. Rationale for Experiments
Figure 3. RT-PCR Applications to the Analysis of Gene Expression in Stem Cell Cultures
and Differentiated Derivatives The experimental rationale, which underlies these experiments, is
to study the expression of a given set of genes that become expressed in a cell-type-specific
manner and which are used, therefore, to identify and characterize different cell types and stages
of differentiation:
Oct-4: This pluripotency marker in ES cells indicates that the presence of
Oct-4 says that the cells have retained their characteristics as stem cells.
β-actin: A housekeeping gene taken as a control for equal loading and
consistency across samples.
7
Nestin and Pax-6: Protestant markers for neural progenitor cells that are
useful in detecting a cell in an early stage of neural differentiation.
Glutamic Acid Decarboxylase: A neuron marker, it would presage that
differentiation into neuronal cell types has occurred.
GABAA α2-Receptor: A receptor associated with mature neurons,
signaling further differentiation and functional maturation.
B. Methodology
RT-PCR: Reverse transcription polymerase chain reaction is a method that generates a
complimentary DNA copy from RNA and then amplifies target DNA sequences (Zheng, et al.
2019). Quantification of gene expression levels can be determined by measuring the quantity of
the amplified products.
Critical Reagents:
Reverse Transcriptase: This is the enzyme synthesizing cDNA from
RNA. Not using this enzyme in control reactions helps to confirm that PCR products are
an RNA derivative and not from contamination by genomic DNA.
DNA Ladder: It is a molecular weight marker which is used to estimate
the size of the PCR products.
Experiment Steps:
RNA Extraction: The RNA will be isolated from the various cell cultures.
cDNA Synthesis: Convert RNA to cDNA using reverse transcriptase.
8
PCR Amplification: The PCR amplification of specific gene sequences
(for example, Oct-4 and Nestin) will be conducted. Include controls with and without
reverse transcriptase to differentiate between true amplification and contamination.
C. Conclusions from Data
Figure 3 shows that according to this data:
ES cells and high-density cultures:
Oct-4 expression: This gene is expressed in ES cells, hence proving that cells under
investigation are pluripotent. Absence of Oct-4 in high-density cultures may suggest
differentiation or loss of pluripotency.
β-actin: The constant expression of β-actin in all samples confirms the integrity of RNA
and is aloading control.
D Neural Progenitor Cells:
Nestin and Pax-6: In will be present in the neuronal progenitor cells, thus positive for
these markers confirms their identity and early differentiation stage (Takahashi, et al. 2007).
Their absence in control reactions without reverse transcriptase also validates the PCR results.
Neuronal Cultures
Glutamic Acid Decarboxylase: Owing to expression in neuronal cultures, successful
differentiation into neuronal cells is reflected (Thomson et al. 1998). No expression in controls
confirms that PCR is specific against the target gene.
DMature Neurons:
9
GABAA α2-Receptor: This gene is expressed to show that the cells have attained a more
mature neuronal stage and are a functional characteristic of mature neurons.
The data support the hypothesis that cell cultures of various types, together with their
derivatives, are truly able to express some of the markers that characterize their differentiation
stage (Reubinoff et al. 2020). These data support the main conclusions: the validity of RT-PCR
for stem cell differentiation probe design and the validity of experimental design on accuracy
toward core gene expression.
Figure 3 therefore provides valuable insights into stem cell differentiation and its trial
intercessions, which can support the experimental process and improve our comprehension of the
biological functions of stem cells.
10
References
Reubinoff, B. E., Pera, M. F., Fong, C. Y., Trounson, A., & Bongso, A. (2000). Embryonic stem
cell lines from human blastocysts: somatic differentiation in vitro.DNature
biotechnology,D18(4), 399-404. https://www.nature.com/articles/nbt0400_399
Takahashi, K., Tanabe, K., Ohnuki, M., Narita, M., Ichisaka, T., Tomoda, K., & Yamanaka, S.
(2007). Induction of pluripotent stem cells from adult human fibroblasts by defined
factors.Dcell,D131(5), 861-872. https://www.cell.com/cell/fulltext/S0092-8674(07)01471-
7?simple=True
Thomson, J. A., Itskovitz-Eldor, J., Shapiro, S. S., Waknitz, M. A., Swiergiel, J. J., Marshall, V.
S., & Jones, J. M. (1998). Embryonic stem cell lines derived from human
blastocysts.Dscience,D282(5391), 1145-1147.
https://www.science.org/doi/abs/10.1126/science.282.5391.1145
Zheng, Y., Xue, X., Shao, Y., Wang, S., Esfahani, S. N., Li, Z., ... & Fu, J. (2019). Controlled
modelling of human epiblast and amnion development using stem
cells.DNature,D573(7774), 421-425. https://www.nature.com/articles/s41586-019-1535-2
